Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Report 2017

Name: Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Report 2017
Brand: QYResearch
SKU: G92DAC48C2DEN
Price: 4000 USD
Availability: InStock

February 2017 | 129 pages | ID: G92DAC48C2DEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

Notes:

Sales, means the sales volume of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

Revenue, means the sales value of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

This report studies sales (consumption) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Astellas Pharmaceuticals
Actavis
Pfizer
GlaxoSmithKline
Salix Pharmaceuticals Ltd
AstraZenenca

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in these regions, from 2011 to 2021 (forecast), like

United States
China
Europe
Japan
Southeast Asia
India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

Preface
Eluxadoline
Alosetron
Rifaximin
Loperamide
Diphenoxylate + Atropine
Dicyclomine and Hyoscyamine

Split by applications, this report focuses on sales, market share and growth rate of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in each application, can be divided into

Hospitals
Clinics
Others

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Report 2017

1 IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS OVERVIEW

1.1 Product Overview and Scope of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
1.2 Classification of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
  1.2.1 Preface
  1.2.2 Eluxadoline
  1.2.3 Alosetron
  1.2.4 Rifaximin
  1.2.5 Loperamide
  1.2.6 Diphenoxylate + Atropine
  1.2.7 Dicyclomine and Hyoscyamine
1.3 Application of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Others
1.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Regions
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2012-2022)
  1.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competition by Manufacturers
  2.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share of Key Manufacturers (2012-2017)
  2.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Share by Manufacturers (2012-2017)
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume and Value) by Type
  2.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume and Value) by Regions
  2.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Regions (2012-2017)
  2.3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Regions (2012-2017)
2.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume) by Application

3 UNITED STATES IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)
  3.1.1 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
3.2 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers
3.3 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type
3.4 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

4 CHINA IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)
  4.1.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
4.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers
4.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type
4.4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

5 EUROPE IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)
  5.1.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
5.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers
5.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type
5.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

6 JAPAN IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)
  6.1.1 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
6.2 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers
6.3 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type
6.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

7 SOUTHEAST ASIA IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type
7.4 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

8 INDIA IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)
  8.1.1 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
8.2 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers
8.3 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type
8.4 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

9 GLOBAL IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS MANUFACTURERS ANALYSIS

9.1 Astellas Pharmaceuticals
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
    9.1.2.1 Preface
    9.1.2.2 Eluxadoline
  9.1.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Actavis
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
    9.2.2.1 Preface
    9.2.2.2 Eluxadoline
  9.2.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Pfizer
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
    9.3.2.1 Preface
    9.3.2.2 Eluxadoline
  9.3.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
    9.4.2.1 Preface
    9.4.2.2 Eluxadoline
  9.4.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Salix Pharmaceuticals Ltd
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
    9.5.2.1 Preface
    9.5.2.2 Eluxadoline
  9.5.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 AstraZenenca
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
    9.6.2.1 Preface
    9.6.2.2 Eluxadoline
  9.6.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview

10 IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS MAUFACTURING COST ANALYSIS

10.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
10.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS MARKET FORECAST (2017-2022)

14.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate Forecast (2017-2022)
  14.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price and Trend Forecast (2017-2022)
14.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.1 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table Classification of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Global Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type in 2015
Figure Preface Picture
Figure Eluxadoline Picture
Figure Alosetron Picture
Figure Rifaximin Picture
Figure Loperamide Picture
Figure Diphenoxylate + Atropine Picture
Figure Dicyclomine and Hyoscyamine Picture
Table Applications of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Global Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application in 2015
Figure Hospitals Examples
Figure Clinics Examples
Figure Others Examples
Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales of Key Manufacturers (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Manufacturers
Figure 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Manufacturers
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers
Table 2016 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate by Type (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Regions (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Regions (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Regions (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
Table United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2012-2017)
Table United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Manufacturers (2012-2017)
Table United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2012-2017)
Table United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type (2012-2017)
Table United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2012-2017)
Table United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2012-2017)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2012-2017)
Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Manufacturers (2012-2017)
Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2012-2017)
Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type (2012-2017)
Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2012-2017)
Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2012-2017)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2012-2017)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Manufacturers (2012-2017)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2012-2017)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type (2012-2017)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2012-2017)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2012-2017)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
Table Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2012-2017)
Table Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Manufacturers (2012-2017)
Table Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2012-2017)
Table Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type (2012-2017)
Table Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2012-2017)
Table Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2012-2017)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
Table Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2012-2017)
Table Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Manufacturers (2012-2017)
Table Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2012-2017)
Table Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type (2012-2017)
Table Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2012-2017)
Table Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2012-2017)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)
Table India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2012-2017)
Table India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Manufacturers (2012-2017)
Table India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2012-2017)
Table India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type (2012-2017)
Table India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2012-2017)
Table India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2012-2017)
Table Astellas Pharmaceuticals Basic Information List
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Global Market Share (2012-2017)
Table Actavis Basic Information List
Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Global Market Share (2012-2017)
Table Salix Pharmaceuticals Ltd Basic Information List
Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Global Market Share (2012-2017)
Table AstraZenenca Basic Information List
Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2015
Table Major Buyers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table Distributors/Traders List
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Regions (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Type (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Application (2017-2022)

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports